use of glucocorticoids for treatment of sepsis has waxed and waned during the past several decades, and recent randomized controlled trials have evoked a reassessment of this therapy. Most glucocorticoid actions are mediated by its specific intracellular receptors (GRs). Thus we initially evaluated whether sepsis and high-dose corticosteroid therapy can regulate guinea pig pulmonary expression of GRs: active receptor, GR␣, and dominant negative receptor, GR␤. Sepsis induction by LPS injection (300 g/kg ip) decreased mRNA and protein levels of GR␣ and increased protein expression of GR␤ in lungs. High-dose methylprednisolone (40 mg/kg ip), administered simultaneously with LPS, markedly potentiated the decrease in GR␣ expression but slightly affected the increase in GR␤ expression. Consequently, this led to a significant reduction in GR␣ nuclear translocation. Nevertheless, methylprednisolone treatment strongly eliminated LPS induction of NF-B activity, as determined by NF-B nuclear translocation and by gel mobility shift assays. Furthermore, the LPS-induced increase in inflammatory cells in bronchoalveolar lavage fluid was blunted by administration of the corticosteroid. On the other hand, immunofluorescent staining for cleaved caspase-3 showed a marked increase in this proapoptotic marker in lung sections, and terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling (TUNEL) represented an enhanced appearance of cell apoptosis in lungs and spleen when methylprednisolone was given together with LPS. Cell apoptosis is now considered to play a role in the pathogenesis of septic syndrome. We thus suggest that the action of glucocorticoids at high doses to accelerate sepsis-induced cell apoptosis may overwhelm their therapeutic advantages in septic shock. lung inflammation; nuclear factor-B
lung inflammation; nuclear factor-B DESPITE ADVANCES IN SUPPORTIVE care, severe sepsis and septic shock continue to be the leading cause of death in critically ill patients (33) . A major factor contributing to the high morbidity and high mortality of septic shock is the lack of an effective treatment (46) . Corticosteroids have been used for treatment of sepsis since the 1950s. Their fundamental roles in stress response to infection and increasing knowledge of the antiinflammatory and immunosuppressive pharmacodynamic profile have been the rationale for its use in sepsis trials for decades. However, the current trend favors the use of corticosteroids, especially in the setting of septic shock and relative adrenal insufficiency (2, 11) . Several randomized controlled trials suggest that prolonged administration of "low" doses of corticosteroids in patients with sepsis and acute respiratory distress syndrome (ARDS) improves clinical outcomes (2, 7, 8, 38) . These results may be in agreement with the concept of impaired adrenocortical reserve in septic shock (9, 48, 50) . Such a beneficial effect was not seen in trials using high-dose methylprednisolone. The harmful effect of high-dose methylprednisolone may be due to immunosuppression and increased incidence of secondary infections (39) . Moreover, quite recent clinicoepidemiologic studies have not provided any support for the routine use of methylprednisolone for treatment of ARDS (44, 51) .
Potential molecular mechanisms underlying the harmful effect of high-dose corticosteroid therapy on the outcome of sepsis are insufficiently understood. We designed a study seeking to highlight the molecular changes in lung tissues associated with high-dose corticosteroid therapy in an in vivo guinea pig model of endotoxin challenge. In this study, methylprednisolone was used for corticosteroid therapy, since it was the most frequently used glucocorticoid at high doses in patients with sepsis and/or ARDS because of its high renal clearance (38, 44, 51) .
The apheliotropic actions of glucocorticoids in the cell are mediated through an intracellular glucocorticoid receptor (GR) (56) . In the nucleus, GR binds as a homodimer to glucocorticoid response elements (GREs) on the DNA to transactivate target genes, which may be positive or negative, either activating or repressing transcription (5, 32) . This mode of GR action is generally considered to be responsible for GR-mediated side effects. Another mechanism of GR action is currently thought to be important for most of the GR anti-inflammatory functions, which is based on the ability of liganded GR monomers to interact directly with other proinflammatory transcription factors, such as NF-B, thereby repressing or potentiating their activity (17) . GR gene transcription may be crucially changed after induction of sepsis, although conflicting results have been reported concerning the effect of sepsis on GR expression (29, 49, 52, 53, 54) . Therefore, the first aim of the present study was to investigate the effect of high-dose corticosteroid therapy on GR expression in septic guinea pig lungs using immunohistochemistry, Western blotting, and RT-PCR analyses.
Glucocorticoid-mediated regulation of apoptosis has been described in a number of different cells and tissues, including thymocytes and neurons (4, 45) . Most of these effects can contribute to the immunosuppressive and antineoplastic action of glucocorticoids but may be involved in their unwanted effects, which would limit their therapeutic use. Recently, cell apoptosis has been implicated playing an important role in the development of organ failure and mortality associated with sepsis (42) . In this setting, lymphocytes and parenchyma cells, including intestinal and lung epithelial cells, as well as vascular endothelial cells undergo apoptotic death (20, 25, 60) . Therefore, the second aim was to assess whether this high-dose corticosteroid therapy can significantly affect lung apoptosis in the guinea pig septic model.
MATERIALS AND METHODS

Animals and treatments.
This study was conducted in accordance with the National Institutes of Health guidelines on the use of laboratory animals and with approval of the Animal Care and Use Committee of the University of Toyama. Male Hartley guinea pigs, weighing 300 -400 g, were housed in an environment with controlled temperature (22-23°C), constant humidity (55-60%), and a daily 12-h light-dark cycle. Standard chow and drinking water were provided ad libitum. A period of at least 7 days was allowed for acclimatization before any experimental manipulation was undertaken.
The guinea pigs were divided into two groups in a random block design and injected intraperitoneally with LPS (300 g/kg; Escherichia coli 055; List Biological Laboratories, Campbell, CA) or an equivalent volume of sterile saline. Intraperitoneal treatment with methylprednisolone (40 mg/kg) was performed contemporaneously to LPS or saline. After 24 h from LPS or saline injection, the animals were killed by an overdose of pentobarbital.
Western blot analysis. After being removed and rinsed in sterilized PBS on ice, lungs were homogenized and then centrifuged at 600 g for 10 min to pellet any insoluble material. The protein concentration of supernatant was determined using a BCA Protein Assay Kit (Pierce; Rockford, IL). When the nuclear extract was used for the sample, it was prepared from lung tissues as demonstrated in our previous study with minor modification (34) . Samples (10 -20 g of protein) were run on 7.5% SDS-polyacrylamide gels. Blotting procedures, chemiluminescent detection, and densitometric analysis were carried out as previously described by our laboratory (34 -36) . Membranes were probed with anti-GR (Calbiochem, San Diego, CA), anti-GR␤ (Calbiochem), anti-NF-B p65 (Cell Signaling Technology, Danvers, MA), anti-lamin B (PROGEN Biotechnik, Heidelberg, Germany), and anti-actin (GeneTex, San Antonio, TX).
Immunofluorescence and confocal analysis. As previously described (34), the trachea was cannulated, and the lungs were gently inflation-fixed en bloc with 4% buffered formalin solution. Inflationfixed lungs were harvested, postfixed in 4% paraformaldehyde overnight, immersed in sucrose solutions, dipped into OCT compound (Sakura Finetechnical, Tokyo, Japan), and frozen at Ϫ20°C. The tissues were then sectioned at a thickness of 30 m and air dried. For immunohistochemical determination of target molecules, the tissue sections were exposed to the fluorescent antibody after overnight incubation with the primary antibody, according to the method in our (36) previous study with minor modification. The following commercially available antibodies were used: anti-GR antibody, anti-cytokeratin antibody (Sigma Chemical, St. Louis, MO), anti-surfactant protein C (SP-C) antibody (Chemicon, Temecula, CA), anti-von Willebrand factor (vWF) antibody (Chemicon), anti-CD68 antibody (AbD Serotec, Kidlington, Oxford, United Kingdom), anti-␣-smooth muscle actin (␣SMA) antibody (Sigma Chemical), and anti-cleaved caspase-3 antibody (Cell Signaling Technology). Zenon labeling technology (Molecular Probes, Eugene, OR) was used in experiments where multiple primary antibodies of the same type were present. The nucleus was counterstained with Hoechst 33258 (Nacalai Tesque, Kyoto, Japan). Immunofluorescent images were observed under Olympus BX51 fluorescence microscope or Leica TCS-SP5 confocal system.
RNA extraction and RT-PCR. Total RNA was isolated from lung tissues with the use of a TRI reagent (Sigma Chemical) according to the manufacturer's instructions. RNA was reverse-transcribed to Fig. 1 . Effect of treatment with methylprednisolone (GC; 40 mg/kg ip) on glucocorticoid receptor-␣ (GR␣) expression in lungs from control and LPS-challenged guinea pigs. In A and B, GR␣ protein expression levels were assessed in the total and nuclear fractions, respectively. In the top trace of each panel, typical Western blots are shown. Actin served as loading control, and lamin B as a nuclear membrane marker. In C, GR␣ mRNA and ␤-actin mRNA were evaluated by RT-PCR as described in MATERIALS AND METHODS, and a representative example of ethidium bromide-stained agarose gels is shown. Values are means Ϯ SE; n ϭ 4. *P Ͻ 0.05 vs. control; #P Ͻ 0.05 vs. LPS alone.
cDNA, and PCR was performed using a Takara RNA PCR kit (Takara Shuzo, Ohtsu, Japan) as described in the manufacturer's manual. Expression of the GR gene was monitored by PCR with 5Ј-CCCTG-GATGTATGACCAATG-3Ј (sense) and 5Ј-AGTAGTTTTTTGAT-GTCTCC-3Ј (antisense). The PCR-amplified product was analyzed by agarose gel electrophoresis. The internal standard used was the ubiquitously expressed house keeping gene ␤-actin, which was amplified with 5Ј-ACTCTCCACCTTCCAGCAGA-3Ј and 5Ј-AAAGCCAT-GCCAATCTCATC-3Ј primers producing a 176-bp fragment.
Nuclear extraction and EMSA. Nuclear protein extracts from freshly isolated lungs were obtained with a commercially available nuclear extraction kit (Sigma Chemical) as described in the manufacturer's manual. For the detection of NF-B DNA binding activity, double-stranded oligonucleotides with consensus sequences of NF-B (5Ј-AGT TGA GGG GAC TTT CCC AGG C-3Ј; Santa Cruz Biotechnology, Santa Cruz, CA) were end labeled with [␥-32 P]ATP (4,500 Ci/mmol at 10 Ci/l; MP Biomedicals, Solon, OH) as recommended by the manufacturer (Takara Shuzo). The DNA binding reaction was conducted, and then samples were loaded onto a 5% polyacrylamide gel and run at 100 V for ϳ60 min after adding bromphenol blue and xylene cyanol. Gels were then dried under a vacuum and subjected to autoradiography.
Cell counting in bronchoalveolar lavage fluid. Under anesthesia with pentobarbital, the lungs were gently lavaged two times with 5 ml of PBS containing heparin, and lavage fluid was pooled. The recovery ratio of pooled lavage fluid ranged from 81% to 88% and did not differ significantly among the groups. The bronchoalveolar lavage fluid (BALF) was then centrifuged at 1,000 g for 15 min to separate cells from the supernatant. Cells were resuspended in PBS and counted with a hemocytometer. Slides were stained with May-Giemsa stain, and cell differential was tabulated using light microscopy at ϫ400 magnification.
Apoptotic cell detection. Terminal deoxynucleotidyl transferase (Tdt) dUTP-mediated nick-end labeling (TUNEL) was performed using the ApopTag Plus Peroxidase In Situ Apoptosis Detection Kit (Chemicon) according to the manufacturer's instructions. In brief, paraffin sections (4-m thick) were digested with 20 g/ml proteinase K (Takara Shuzo) for 10 -15 min at room temperature and reacted with Tdt enzyme for 60 min at 37°C. The sections were then incubated with anti-digoxigenin conjugate at room temperature for 30 min, Relative levels of GR␣ expression in different tissues of guinea pigs. In A, GR␣ protein expression in different tissues was compared with the relative level using the housekeeping protein actin. For relative protein quantification, the expression level in lungs was set to 1. Values are means Ϯ SE; n ϭ 4. In B, the effect of treatment with GC (40 mg/kg ip) on GR␣ expression was assessed in kidney and spleen from control and LPS-challenged guinea pigs. Typical Western blots and a bar graph summarizing the immunoblot data are shown. Values are means Ϯ SE; n ϭ 4. *P Ͻ 0.05 vs. control; #P Ͻ 0.05 vs. LPS alone.
followed by incubation with diaminobenzidine solution and counterstained with methyl green. Apoptotic cells were observed in crosssection in randomly selected microscopic fields at a final magnification of ϫ400.
Serum cortisol assay. Guinea pig blood was collected into microtubes and centrifuged to obtain serum. Serum cortisol assays were performed with the use of the ADVIA Centaur Assay (Bayer Medical, Tokyo, Japan) in accordance with the manufacturer's guidelines. This method showed no cross-reactivity with other steroid hormones such as aldosterone, progesterone, and testosterone, and the assay limit of sensitivity was 0.2 g/dl with an interassay variation of Յ10%.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical assessment of the data was made by one-way ANOVA with repeated measurements followed by Bonferroni multiple-comparison test when appropriate. A P value of Ͻ0.05 was considered to be statistically significant.
RESULTS
Effect of endotoxin on serum cortisol. At 3 h after LPS administration to the guinea pig, the serum cortisol level was elevated from 51 Ϯ 4 (n ϭ 10) to 142 Ϯ 40 g/dl (n ϭ 6). This elevation at the 3-h time point was variable from animal to animal but was statistically significant (P Ͻ 0.01). Serum cortisol increased approximately sixfold from baseline at 6 h after endotoxin (309 Ϯ 9 g/dl, n ϭ 6; P Ͻ 0.001). Thereafter, cortisol levels returned to baseline values at 24 h (49 Ϯ 3 g/dl, n ϭ 13). The serum level of cortisol remained at baseline values in animals treated with normal saline.
Expression of GR in lungs and other tissues. To examine the effects of methylprednisolone treatment and sepsis on protein expression of GR␣, an isotype mediating the hormone action, the expression levels of GR␣ protein in lung tissues were evaluated by Western blotting using an antibody specific for GR␣ isoform. As presented in Fig. 1A , treatment of guinea pigs with 40 mg/kg methylprednisolone showed a significant decrease in total GR␣ protein expression in lungs. When sepsis was induced by intraperitoneal injection of 300 g/kg LPS, the total expression level of GR␣ was significantly decreased. A more marked reduction in total GR␣ protein expression was found in lungs from the animals treated with methylprednisolone coadministered with LPS. On the other hand, methylprednisolone treatment and sepsis induction each resulted in a significant increase in GR␣ protein levels in nuclear fractions obtained from lungs (Fig. 1B) . To our surprise, however, the GR␣ level in the nuclear fraction was dramatically reduced when the corticosteroid was given together with LPS.
GR␣ mRNA expression levels in lung tissues were analyzed by semiquantitative RT-PCR (Fig. 1C) . The mRNA level of GR␣ was evidently reduced by methylprednisolone treatment. Also, downregulation of GR␣ mRNA was observed in lungs after sepsis induction with LPS. When the effect of the corticosteroid coadministered with LPS was examined, pulmonary GR␣ mRNA showed a more striking reduction than with each treatment alone.
Immunofluorescent staining for GR␣ confirmed the results obtained by immunoblot analysis. Thus immunoreactivity for GR␣ was less abundant in lung tissues from guinea pigs after sepsis induction with LPS or after treatment with methylprednisolone compared with that observed in control lung tissues. Furthermore, when methylprednisolone was given together with LPS challenge, strongly reduced immunofluorescent staining for GR␣ was observed in guinea pig lung tissues (Fig. 2) .
The relative expression of GR␣ protein in several control tissues is shown in Fig. 3A . GR␣ was highly expressed in lungs. Kidney and spleen expressed about 50 -70% of the level in lungs, whereas the expression level of GR␣ in heart was only 37% and in liver was less than 10% that of lungs. In both kidney and spleen, after methylprednisolone treatment or LPS challenge, GR␣ protein levels were decreased, and this decrease was more marked when the corticosteroid was given together with LPS (Fig. 3B) , which essentially corresponded with the results obtained in lungs.
We also compared pulmonary expression levels of GR␤, which does not bind glucocorticosteroids and is transcriptionally inactive (3, 40, 41) , after methylprednisolone treatment and sepsis induction. As presented in Fig. 4 , Western blotting results showed that the total expression level of GR␤ protein was greatly reduced in lungs from guinea pigs treated with methylprednisolone compared with the control group. In contrast, sepsis induction with LPS resulted in a significant increase in total GR␤ protein expression in lungs. This sepsisinduced increase in total GR␤ protein expression was significantly but incompletely inhibited by methylprednisolone treatment. GR␤ was undetectable in the nuclear fraction regardless of whether corticosteroid or LPS was administered.
In an attempt to identify the localization of GR␣ in the lung, immunofluorescent labeling techniques were conducted. Double labeling of normal guinea pig lung tissues using GR antibody with the type I and type II cell marker, cytokeratin, or the type II cell marker, SP-C, showed that neither type I nor type II cells were the major cells to express GR␣ in alveoli (Fig. 5, A and B) . In addition, colocalization of GR␣ with the vascular endothelial cell marker, vWF, was not observed (Fig.  5C ). Furthermore, lung sections from normal animals were triple labeled for macrophages and vascular smooth muscle cells with GR␣, using specific markers, CD68 and ␣SMA. Triple labeling indicates that macrophages and vascular smooth muscle cells do not stain for GR␣ (Fig. 5D) .
Effect of methylprednisolone on septic lung inflammation. To examine the activation of NF-B in guinea pig lungs, we measured NF-B translocation to the nucleus with the antibody to an NF-B subunit of p65. As depicted in Fig. 6A , translocation of NF-B to the nucleus was markedly increased in lungs from guinea pigs after sepsis induction with LPS. Methylprednisolone effectively abolished this sepsis-triggered NF-B nuclear translocation. Furthermore, analysis of NF-B binding activity was performed in nuclear protein extracts from lungs by gel mobility shift assays (Fig. 6B) . LPS challenge led to an increase in NF-B binding activity. This induction of NF-B binding activity by LPS was effectively eliminated when methylprednisolone was given to the animals. The addition of excess unlabeled NF-B oligonucleotides competed with labeled NF-B probe, demonstrating the specificity of the protein/DNA interaction (Fig. 6B, lane 6) .
As shown in Fig. 7 , quantitation of inflammatory cells detected in BALF represented a significant increase in the animals after sepsis induction with LPS compared with the control group. The sepsis-induced increase in BALF cell counts was blunted by treatment with methylprednisolone. Staining for differential counting showed the lavage cells contained Ͼ60% macrophages in all studies. This proportion remained substantially unchanged by sepsis induction and corticosteroid therapy. Thus many of inflammatory cells that displayed an evident increase in numbers after sepsis induction were macrophages.
Effect of methylprednisolone on sepsis-induced cell apoptosis. As depicted in Fig. 8 , immunofluorescent staining for the cleaved form of caspase-3, a member of the caspase superfamily that initiates cell apoptotic events, showed that its protein expression was clearly detectable in lungs from methylprednisolone-treated or LPS-challenged guinea pigs but not in control lungs. Methylprednisolone, administered simultaneously with LPS, resulted in a much greater increase in activated caspase-3 in lungs compared with each treatment alone. In A, no apparent difference in p65 expression in the total fraction among groups is shown. In B, the induced NF-B shift bands are indicated. Lane 1, free probe showed no detection of NF-B binding activity; lane 2, nuclear extracts from control guinea pig lung tissues were incubated with a 32 P-labeled NF-B probe; lane 3, nuclear extracts were taken from lungs of the guinea pig at 24 h after GC treatment; lane 4, nuclear extracts were taken from lungs of the guinea pig at 24 h after LPS challenge; lane 5, nuclear extracts were taken from lungs of the guinea pig at 24 h after coadministration of LPS and GC; lane 6, nuclear extracts from lung tissues of septic guinea pigs were incubated with a 32 P-labeled NF-B probe in the presence of excess unlabeled NF-B oligonucleotides. Results shown are representative of at least 3 independent experiments.
To assess whether sepsis and corticosteroid therapy can modify apoptotic cell death, the tissues were labeled with an in situ TUNEL assay. As shown in Figs. 9 and 10, TUNELpositive apoptotic cells in lungs were evidently increased when sepsis was induced with LPS. In guinea pigs treated with methylprednisolone coadministered with LPS, TUNEL-positive cells had a tendency to further increase. This was more striking in spleen tissues. When the corticosteroid was given together with LPS, a marked increase in TUNEL-positive blood cells was observed. Significant increases in TUNELpositive apoptotic cells in lung and spleen tissues were found when guinea pigs were given methylprednisolone alone, although this effect tended to be less pronounced compared with its administration to the LPS-treated animals. Treatment with low-dose hydrocortisone (5 mg⅐kg Ϫ1 ⅐day Ϫ1 ip, 7 days) did not cause any increase in apoptotic cells in either lungs or spleen of guinea pigs [TUNEL-positive cells: 0.38 Ϯ 0.04 for lung; 2.05 Ϯ 0.31 for spleen (compare with controls in Fig. 10) ].
DISCUSSION
Glucocorticoids have been the first, among anti-inflammatory agents, to be tested in large randomized controlled trials in septic shock, but their use is still controversial. In the Annane et al. (2) trial, it has been suggested that corticosteroid therapy reduces the morbidity effect of septic shock and may favorably affect survival from sepsis. On the other hand, several randomized controlled trials have shown unequivocally no value of high-dose glucocorticoid administration in patients with septic shock and ARDS (27, 44, 51, 59) . In the present study, methylprednisolone treatment of guinea pigs was performed at a high dose (40 mg/kg ip). We found that high-dose methylprednisolone decreased expression of GR␣ in guinea pig lungs. Furthermore, sepsis, induced by LPS, resulted in a significant decrease in pulmonary expression of GR␣. Interestingly, when the corticosteroid was given together with LPS, the GR␣ expression level in lungs was reduced much more than with each treatment alone. There was a significant correlation between decreases in GR␣ protein and mRNA levels, as determined by RT-PCR analysis. This parallel behavior of protein and mRNA expression implies that the expression level of GR␣ in lung tissues is regulated in a transcriptional manner by both sepsis induction and corticosteroid therapy.
In accordance with previous studies showing that plasma levels of glucocorticoids are elevated during sepsis (21, 22) , we found a marked increase in serum cortisol levels in guinea pigs treated with LPS in a time-dependent fashion. Increased glucocorticoids would be generally associated with downregulation of expression and ligand binding activity of GRs (11, 15, 43, 47, 55) . Our observations that GR␣ expression was significantly decreased in lungs as well as kidney and spleen from LPS-induced septic guinea pigs are in close agreement with the results of other investigators showing that sepsis can downregulate GR numbers in different cell types and tissues (29, 52, 53) . Furthermore, LPS infusion in pigs has been shown to downregulate GR expression in systemic organs, including lungs (16) . Thus endotoxemia and/or sepsis appear to result in a general reduction in systemic GR␣ expression levels. In another study, however, the production and amount of GRs have been documented showing an increase in skeletal muscle during sepsis (54) . The reasons for such unexpected results may be related to differences in animal age and species, septic models, and/or tissues used in that study, but the apparent discrepancy could be explained by the possibility that the increased number of GRs was reflective of an increase in GR␤ levels being included. In contrast to GR␣, GR␤ interacts weakly with heat shock protein, does not bind glucocorticoids, and is transcriptionally inactive (12, 18) . Various studies have shown that GR␤ exerts a dominant-negative effect on GR␣ transcription of target genes, which may involve competition between GR␣ and GR␤ for binding to GREs, competition for coactivators in the nucleus, as well as formation of GR␣-GR␤ heterodimers, which are transcriptionally inactive (3, 14, 58) . Our study demonstrated for the first time that GR␤ expression in lungs was upregulated by sepsis induction with LPS. Although methylprednisolone treatment resulted in a marked reduction in GR␤ expression levels, sepsis-induced GR␤ upregulation was still observed substantially even when the corticosterone was given. Increased expression of GR␤ has been found in several diseases, which are associated with insensitivity to glucocorticoids, suggesting that an increased ratio of GR␤-to-GR␣ may induce glucocorticoid insensitivity (19, 23, 24, 28) . The mechanism underlying the considerable increase in GR␤ expression by sepsis induction is not fully understood, but this change may be important because increased GR␤ in the cytoplasm could interfere with nuclear translocation of GR␣, expression of which is strikingly reduced by sepsis with methylprednisolone treatment, in response to the corticosteroid, plausibly as a result of heterodimer formation between GR␣ and GR␤, leading to lower glucocorticoid sensitivity. Indeed, in lung tissues from septic guinea pigs receiving high-dose methylprednisolone, nuclear translocation of GR␣ was much less pronounced despite our observation that the corticosteroid can induce GR␣ nuclear translocation. It should be noted, however, that the elevated intrinsic glucocorticoid levels played a significant role in increased GR␣ nuclear translocation during sepsis without any corticosteroid therapy.
In guinea pigs, high expression of GR␣ was observed in lungs. The localization and distribution of GRs at mRNA and protein levels have also been demonstrated in human lungs by means of in situ hybridization and immunohistochemistry (1). Our immunofluorescent labeling study indicated that there was little expression of GR␣ observed in type I and type II cells, vascular endothelial and smooth muscle cells, and CD68-positive macrophages of guinea pig lung tissues. Thus we did not clarify well the localization of GR␣ in lungs from the present study. Additional work will be required to understand precise knowledge of the identity of GR␣ localization in lungs.
In light of the present data showing that high-dose methylprednisolone administration in septic guinea pigs caused downregulation of GR␣ and upregulation of GR␤ expression and consequently led to impairment of GR␣ nuclear translocation, one would expect that most glucocorticoid actions, including anti-inflammatory effects, may be not effectively displayed under such conditions. Indeed, a recent report has revealed that mice with conditional deletion of GR in macrophages are highly susceptible to LPS-induced lethality (6) . To our surprise, however, high-dose methylprednisolone treatment strongly blocked sepsis-induced NF-B activation, as indicated by a significant elimination of increases in nuclear translocation and binding activity of NF-B. NF-B is a proinflammatory transcription factor, and its activation is a central molecular event leading to the development of septic shock and inflammation (30) . In the present study, LPS-induced sepsis resulted in a significant increase in the number of inflammatory cells from the BALF of guinea pigs, which was blunted by high-dose methylprednisolone treatment. Since nuclear translocation of GR␣ can transrepress inflammatory gene activation via direct interaction with NF-B (31), we interpret the present observations to indicate that impaired GR␣ nuclear translocation seen in septic guinea pigs treated with high-dose methylprednisolone appeared to minimally mitigate the anti-inflammatory actions of the corticosteroid.
Recent accumulating evidence suggests that apoptosis plays an important role in the pathophysiology of sepsis, and apoptosis may be potentially detrimental in septic acute lung injury. Studies with the use of transgenic and gene knockout mice, providing protection against apoptotic cell death, have shown that these animals can exhibit a significant survival benefit in polymicrobial sepsis (13, 26) . Moreover, we (37) and others (57) have demonstrated that silencing of gene transcripts necessary for apoptosis, such as Fas and caspase-8/caspase-3 via RNA interference, significantly improves the survival of septic mice. Glucocorticoids are known to induce apoptosis through mitochondria-derived caspase-9 activation of caspase-3 (42) . In the present study, immunofluorescent staining for activated caspase-3 was enhanced, and the appearance of TUNELpositive cells was further increased in septic guinea pig tissues treated with high-dose methylprednisolone. This shows that the increased process of cell apoptosis that occurs during sepsis can be significantly aggravated when glucocorticoid treatment is performed at high doses. In particular, extensive apoptosis of blood monocytes, including lymphocytes, would bear the risk of aggravated immunosuppression and increased incidence of secondary infections. Severe immunosuppression is one of the clinically important adverse effects accompanying corticosteroid therapy in septic shock. We thus suggest that glucocorticoid-induced cell apoptosis may be one of the mechanisms by which high-dose corticosteroid therapy can display a detrimental effect on septic mortality.
In conclusion, we showed that high-dose methylprednisolone administration in LPS-induced septic guinea pigs resulted in remarkable changes in expression of GRs in lungs, downregulated GR␣, and upregulated GR␤, leading to impaired GR␣ nuclear translocation. Nevertheless, the ability of the corticosteroid to mitigate sepsis-induced NF-B activation and lung inflammation was evidently preserved. Sepsis induction led to a significant increase in cell apoptosis, which was apparently enhanced by glucocorticoid treatment. Therefore, our present results suggest that the action of glucocorticoids to accelerate sepsis-induced cell apoptosis may overwhelm the therapeutic benefit of glucocorticoids in sepsis.
